Discover how innovative physical therapy, smart medications, nutrition strategies and mind-body techniques are transforming ...

Pamela Bach was still allegedly suffering from the injuries she obtained from a 2003 motorcycle accident with her ex-husband, David Hasselhoff. The late actress’ friend addressed Bach’s devastating ...

Vertex's Journavx, a new non-opioid pain drug, lands Tier 3 on Optum Rx formularies. Vertex reports $2.91 billion Q4 sales.

Vertex Pharmaceuticals operates in a profitable subsector and is poised for further success, says Dr Michael Tubbs ...

While the NFL’s policy on THC has become more lenient in recent years, it was put into the spotlight this week after former player Adam “Pacman” Jones appeared on Deion Sanders’ Tubi show “We Got Time ...

A multidisciplinary team of University of Cincinnati Cancer Center researchers is leading a new clinical trial aimed to optimize pain management and reduce the need for opioids after mastectomy ...

Optum Rx, the pharmacy benefit manager owned by UnitedHealth Group, placed Journavx on some of its commercial formularies in ...

Researchers create a cannabis-derived compound that relieves pain without the risk of addiction or mind-altering effects.

The Boston-based company's new medication, called Journavx, is being placed on a tier that means it might be costlier than ...

The company previously announced data from another Phase III trial of cebranopadol, which also met its primary endpoint.

Positive data from a pair of acute pain studies convinced the company that its drug, which works differently than existing ...